Leading Improvement
Since 2019, our short programmes have developed 176 clinicians; impacting nearly 60,000 patients, their families and numerous Trusts all over the UK.
Our short programmes are a fundamental area of our work. They give us the chance to deliver material to target specific areas of the pathway and reach more patients. Our redesigned format run on a 20 week basis and will support you in mobilising change within your organisation.
Submit an application!
We are accepting applications for our Sexual Well-being Programme, apply now!
Our recent and current programmes
We recently finished our Active Surveillance Programme, with 99% of participants recommending it to a colleague.
We are also currently running our Clinical Leads Programme and Primary Care Programme.
The History of our Short Programmes
The Improvement Programmes Team was created by Prostate Cancer UK in 2019. The first two years, we delivered three programmes- Supported Self Management, Clinical Leads (in collaboration with BAUS) and Advanced Disease. These programmes improved prostate cancer care for over 14,000 men.
Due to the impact of the pandemic, Clinical Leads was the only short programme to go ahead in 2021. As a direct result of this programme, over 11,000 patients will have experienced an improvement in quality of prostate cancer care.
Read below to find out more about our most recent impact from our 2022/23 programmes.
Our 2022/23 impact
We've run several successful programmes over the last few years, including Clinical Leads, PROMS and Supported Self-Management. In the last two years we've trained over 100 clinicians and impacted over 20,000 men.
Change and Innovators
This programme developed leadership skills to become changemakers, reaching more than 2,200 patients
Living and Dying Well with advanced prostate cancer
This programme supported clinicians navigating challenges in palliative and end of life care.
Patient Recorded Outcome Measures (PROMS)
Explored using proven measurement methods (PROMS, HNAs + QOL) to improve quality of patient care.
If you'd like to discuss our short programmes, please contact the Improvement Programmes Team.
Our Prostate Cancer UK Improvement Programmes are partly funded by grants from Astellas Pharma Ltd, Bayer UK and Roche Products Ltd. However, none of these organisations have any influence over the educational content of the programmes.